Xponance, Inc. Alaunos Therapeutics, Inc. Transaction History

Xponance, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$0.41 - $1.24 $4,175 - $12,626	-10,183 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$0.62 - $1.17 $6,313 - $11,914	10,183 New	10,183 $7,000
Q3 2021 Nov 05, 2021	SELL	$1.44 - $2.73 $15,891 - $30,128	-11,036 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$2.63 - $3.67 $29,024 - $40,502	11,036 New	11,036 $29,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.